Skip to Content
Global head of Sandoz, Novartis</strong>

He's lived on four continents, travels yearly to 25 countries, and has scaled the peaks of the pharma business to stand atop the second-biggest generic-drug operation in the world, yet George still makes time to take his oldest daughter swimming on weekends. His focused approach has seen him take Sandoz, which did $9.5 billion in revenue last year, into biosimilars. His prescient investment in biosimilars, or generic biologic drugs, has given Sandoz more than 50% of the hot market, and will probably reverse a recent dip in sales growth. 

<strong>It's a gene thing: </strong>The apple didn't fall far from the tree -- his father is Bill George, the best-selling author and former Medtronic CEO, who lectures on leadership at Harvard Business School. 

<em>--M.K.</em>Global head of Sandoz, Novartis</strong>

He's lived on four continents, travels yearly to 25 countries, and has scaled the peaks of the pharma business to stand atop the second-biggest generic-drug operation in the world, yet George still makes time to take his oldest daughter swimming on weekends. His focused approach has seen him take Sandoz, which did $9.5 billion in revenue last year, into biosimilars. His prescient investment in biosimilars, or generic biologic drugs, has given Sandoz more than 50% of the hot market, and will probably reverse a recent dip in sales growth. 

<strong>It's a gene thing: </strong>The apple didn't fall far from the tree -- his father is Bill George, the best-selling author and former Medtronic CEO, who lectures on leadership at Harvard Business School. 

<em>--M.K.</em>
Global head of Sandoz, Novartis</strong> He's lived on four continents, travels yearly to 25 countries, and has scaled the peaks of the pharma business to stand atop the second-biggest generic-drug operation in the world, yet George still makes time to take his oldest daughter swimming on weekends. His focused approach has seen him take Sandoz, which did $9.5 billion in revenue last year, into biosimilars. His prescient investment in biosimilars, or generic biologic drugs, has given Sandoz more than 50% of the hot market, and will probably reverse a recent dip in sales growth. <strong>It's a gene thing: </strong>The apple didn't fall far from the tree -- his father is Bill George, the best-selling author and former Medtronic CEO, who lectures on leadership at Harvard Business School. <em>--M.K.</em>
Global head of Sandoz, Novartis</strong> He's lived on four continents, travels yearly to 25 countries, and has scaled the peaks of the pharma business to stand atop the second-biggest generic-drug operation in the world, yet George still makes time to take his oldest daughter swimming on weekends. His focused approach has seen him take Sandoz, which did $9.5 billion in revenue last year, into biosimilars. His prescient investment in biosimilars, or generic biologic drugs, has given Sandoz more than 50% of the hot market, and will probably reverse a recent dip in sales growth. <strong>It's a gene thing: </strong>The apple didn't fall far from the tree -- his father is Bill George, the best-selling author and former Medtronic CEO, who lectures on leadership at Harvard Business School. <em>--M.K.</em>
  • Age
    39
  • Title
    Global head of Sandoz
  • Company
    Novartis

He’s lived on four continents, travels yearly to 25 countries, and has scaled the peaks of the pharma business to stand atop the second-biggest generic-drug operation in the world, yet George still makes time to take his oldest daughter swimming on weekends. His focused approach has seen him take Sandoz, which did $9.5 billion in revenue last year, into biosimilars. His prescient investment in biosimilars, or generic biologic drugs, has given Sandoz more than 50% of the hot market, and will probably reverse a recent dip in sales growth. It’s a gene thing: The apple didn’t fall far from the tree — his father is Bill George, the best-selling author and former Medtronic CEO, who lectures on leadership at Harvard Business School. –M.K.

Fortune Data StoreLooking for leads, investment insights, or competitive intelligence?Get Premium Access